{{knowledge objective
|Identifiant=OIC-110-14-B
|Item_parent=Sleep disorders in children and adults
|Item_parent_short=Sleep disorders in children and adults
|Rank=B
|Title=Knowing the epidemiological importance of SAS
|Description=None
|Rubric=Prevalence, Epidemiology
|Contributors=Iulia Ioan,Laurianne Coutier
|Order=14}}

In France, nearly 2 million people are thought to suffer from it. It affects 2% of women and 4% of men between the ages of 30 and 60.